Erectile dysfunction in diabetic males: Plausible mechanisms and management strategies

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 2, Issue 1, 2008, Pages 81-86

  Luthra, Atul ^a   Misra, Anoop ^a  

^a FORTIS HOSPITAL   (India)

Author keywords

Diabetic males; Erectile dysfunction; Management; Mechanisms

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; APOMORPHINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CIMETIDINE; CYCLIC GMP; DIGOXIN; FINASTERIDE; FLUOXETINE; GLUCOSE; GLYCERYL TRINITRATE; INSULIN; LEVODOPA; LIPID; NICOTINIC ACID; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT; PAPAVERINE; PHENYTOIN; PHOSPHODIESTERASE V; PROSTAGLANDIN E1; SERTRALINE; SILDENAFIL; SPIRONOLACTONE; UNINDEXED DRUG; VASODILATOR AGENT; YOHIMBINE;

ANGIOGRAPHY; ANXIETY DISORDER; AUTONOMIC NEUROPATHY; BLURRED VISION; CARDIOVASCULAR RISK; COLOR VISION DEFECT; CONFLICT; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE DURATION; DIZZINESS; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG INDUCED HEADACHE; DRUG POTENTIATION; DYSURIA; ERECTILE DYSFUNCTION; EVOKED SPINAL CORD RESPONSE; FLUSHING; GENITAL PAIN; GLYCEMIC CONTROL; HORMONE DETERMINATION; HUMAN; INFECTION; MALE GENITAL SYSTEM; MICROANGIOPATHY; NEUROLOGIC EXAMINATION; ONSET AGE; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PENIS PROSTHESIS; PERIPHERAL VASCULAR SYSTEM; PHYSICAL EXAMINATION; PREVALENCE; PRIAPISM; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; REVIEW; SACRAL SPINAL CORD; SIDE EFFECT; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; VASCULAR DISEASE;

EID: 38849200246     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2007.11.005     Document Type: Review

References (13)

1. National Institutes of Heath Consensus Development Panel on Impotence, JAMA 270 (1999) 83-90.
2. Lee I.C., Surridge D., Morales A., and Heaton J.P. The prevalence and influence of significant psychiatric abnormalities in men undergoing comprehensive management of organic ED. Int J Impot Res 12 (2000) 47-51
3. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., and McKinlay J.B. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging study. J Urol 151 (1994) 54-61
4. Wiles P.G. Erectile impotence in diabetic men: etiology investigation and management. Diabet Med 9 (1992) 888-892
5. Dey L., and Shepherd M.D. Evaluation and treatment of erectile dysfunction in men with diabetes mellitus. Mayo Clin Proc 77 (2002) 276-282
6. Hartman U. The efficacy of psychosexual therapy for erectile dysfunction: a critical review of outcome studies. Int J Impot Res 10 Suppl. 3 (1998) S23
7. Rendell M.S., Rajfer J., Wicker P.A., and Smith M.D. Sildenafil for treatment of erectile dysfunction in diabetes. JAMA (1999) 421-426
8. Webb D.J., Muirhead G.J., Wulff M., Sutton J.A., Levi R., and Dinsmore W.W. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Card 36 (2000) 25
9. Cheitlin M.D., Hutter A.M., Brindis R.G., Ganz P., Kaul S., Russell Jr. R.O., et al. Use of sildenafil in patients with cardiovascular disease. Circulation 99 (1999) 168
10. Ormrod D., Easthope S.E., and Figgitt D.P. Vardenafil. Drugs Aging 19 3 (2002) 217-227
11. Linet O.I., and Orgine F.G. Efficay and safety of intracavernosal alprostadil in men with erectile dysfunction. N Eng J Med 334 (1996) 873-877
12. Padma-Nathan H., Hellstrom W.J.G., Kaiser F.E., Labasky R.F., Lue T.F., Nolten W.E., et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Eng J Med 336 (1997) 1-7
13. Price D.H., Cooksey J., Jedu D., Bentley S., Heamshaw J.R., and Osborn D.E. The management of impotence in diabetic men by vacuum tumescent therapy. Diabet Med 8 (1991) 964-967